|Articles|August 2, 2016
OmniComm Signs Agreement with Research University
OmniComm Systems announced that it has signed an agreement with one of the top five medical research universities in the United States.
Advertisement
OmniComm Systems announced that it has signed an agreement with one of the top five medical research universities in the United States. The university plans to use OmniComm’s TrialMaster EDC and related services to conduct a series of clinical studies over a period of five years.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
3
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
4
Building Broader Investigator Networks to Advance Global Breast Cancer Research
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
